Development and validation of a UHPLC‐MS/MS bioanalytical method to quantify in plasma the analgesic candidate PT‐31 following a preliminary pharmacokinetic study in rats |
| |
| Authors: | T C Bessegato M Niehues G A Buqui N P Lopes I R Pitta S L Galdino T Dalla Costa |
| |
| Affiliation: | 1. Programa de Pós‐Gradua??o em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil;2. Núcleo de Pesquisa de Produtos Naturais e Sintéticos, Universidade de S?o Paulo, Ribeir?o Preto, SP, Brazil;3. Núcleo de Pesquisa em Inova??o Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil |
| |
| Abstract: | A selective and sensitive UHPLC‐MS/MS bioanalytical method to determine PT‐31, an analgesic drug candidate, in rat plasma was developed and validated. Analyses were performed using a UHPLC‐MS/MS system equipped with an electrospray ionization interface operating in the positive ionization mode using a C18 reversed‐phase column with a mobile phase of water:acetonitrile (68:31, v/v) containing 0.1% acetic acid eluting in a gradient mode with a flow rate of 0.3 mL/min. Plasma samples were deproteinized with cold acetonitrile containing 0.01% TFA (1:2, v/v) and 50 μL of the supernatant were injected into the system. PT‐31 and phenytoin (internal standard) retention times were roughly 1.0 and 1.5 min, respectively. Linear standard curves were plotted for the 0.01–10 µg/mL concentration range, with a coefficient of determination > 0.99. The method's precision was over 88%. Maximum intra‐ and inter‐day relative standard deviations were 14.6% and 11.6%, respectively. Interfering substances were not detected in the chromatogram, indicating that the method was specific. PT‐31 stability was assessed under different temperature and storage settings. The method was used to characterize PT‐31 plasma pharmacokinetics following administration of 5 mg/kg i.v. to Wistar rats. Therefore, the method described is sensitive, linear, precise and specific enough to determine PT‐31 in preclinical pharmacokinetic investigations. Copyright © 2015 John Wiley & Sons, Ltd. |
| |
| Keywords: | UHPLC‐MS/MS PT‐31 bioanalytical method validation PT‐ 31 analgesic preclinical pharmacokinetics |
|
|
